Precision medicine for obesity program

Virtual Lecture

Expires: November 18, 2023


In this month’s “Virtual Lecture,” Andres Acosta, M.D., Ph.D., discusses how individualized medicine can play a role in obesity.



Andres Acosta, M.D., Ph.D.

Assistant Professor of Medicine

Department of Gastroenterology and Hepatology

Mayo Clinic, Rochester, Minnesota

Learning objectives

Upon completion of this program, participants should be able to:

  • Review obesity current classifications
  • Describe the heterogeneity of obesity phenotypes
  • Summarize obesity ‘actional-phenotypes’ classification
  • Recognize characteristics of obesity phenotypes
  • Explain phenotype-guided weight loss
  • Discuss biomarker discovery as it relates to the first-of-its-kind obesity phenotype test

Intended audience

This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.


The following types of credit are offered for this event:


Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.

State of Florida

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. This program has been approved for 1.0 contact hour.

To obtain credit

1. Watch the video.

2. Complete the posttest and evaluation that launches immediately following the video.

3. Generate and print your certificate(s).

Level of instruction for this program is intermediate.

Faculty disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.


Contact us:

Photo credit

GettyImages: Clara Murcia

MCL Education

This post was developed by our Education and Technical Publications Team.